Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NONMYELOABLATIVE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CIDP

29 Oct 2007

Abstract excerpt

Most patients with chronic inflammatory demyelinating polyneuropathy (CIDP) initially respond to corticosteroids, immunosuppressive drugs, IV immune globulin (IVIg), and plasma exchange (PE). However, more than half relapse, with some developing a recurrent or persistent clinical course resulting in severe disability and even death.1,2 Nonmyeloablative autologous hematopoietic stem cell transplantation (HSCT) for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Multiple Sclerosis Research Studies
Share to Peripheral Neuropathies and Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17967996
DOI: 10.1212/01.wnl.0000277266.53449.8b

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NONMYELOABLATIVE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY CIDPPMID 17967996Read ↗

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.Semantic proximity Read ↗

Neurologic Status of Patients With Purine Nucleoside Phosphorylase Deficiency Before and After Hematopoetic Stem Cell TransplantationSemantic proximity Read ↗

Emerging novel therapies for steroid-refractory acute graft-versus-host disease: recent advances and future directionsSemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisSemantic proximity Read ↗

Haematopoietic stem cell transplantation for <scp>SCID</scp> patients: where do we stand?Semantic proximity Read ↗

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosisSemantic proximity Read ↗

Transplantation of bone marrow stromal cells for treatment of central nervous system diseases.Semantic proximity Read ↗

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantationSemantic proximity Read ↗

B-Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Multiple SclerosisSemantic proximity Read ↗

A Single Institution Experience of Bortezomib for GVHD in a Pediatric HSCT PopulationSemantic proximity Read ↗

Successful treatment with rituximab and mycophenolate mofetil of refractory autoimmune hemolytic anemia post-hematopoietic stem cell transplant for dyskeratosis congenita due to TINF2 mutation.Semantic proximity Read ↗

Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children: Analysis of Prognostic FactorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.